EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Concurrent loss of RB1 facilitates EGFR-TKI resistance in EGFR-mutant lung cancer by modulating histone crotonylation

Sihong Chen, Xiaoyuan Wang, Qihao Xuan, Chang Liu, Youwei Su, Zongang Liu, Lina Jia, Yi Ren, Wei Cui, Xinyu Fan, Lihui Wang

Acta Pharmaceutica Sinica B · 2026-11 · 16 (11) · 7307-7324

DOI: 10.1016/j.apsb.2026.08.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Sihong Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Benxi Institute of Pharmaceutical Research, Shenyang Pharmaceutical University, Shenyang 110016, China. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Science & Technology of Liaoning Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

EGFR-TKI resistanceEGFR/RB1 co-mutationsH3K23crHistone crotonylationLung cancerMAPK signalingMetabolic reprogrammingPEBP1/RKIP

Autor:innen und Institutionen

  • Benxi Institute of Pharmaceutical Research, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Department of Pharmacology, School of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Department of Thoracic Surgery, Chest Hospital of Shenyang Pharmaceutical University, Shenyang 110044, China.
  • Department of Thoracic Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, China.
  • Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang 110004, China.

Förderung

  • Department of Science & Technology of Liaoning Province
  • National Natural Science Foundation of China

Zitieren

APA

Chen, S., Wang, X., Xuan, Q., Liu, C., Su, Y., Liu, Z., Jia, L., Ren, Y., Cui, W., Fan, X., & Wang, L. (2026). Concurrent loss of RB1 facilitates EGFR-TKI resistance in EGFR-mutant lung cancer by modulating histone crotonylation. Acta Pharmaceutica Sinica B, 16(11), 7307-7324. https://doi.org/10.1016/j.apsb.2026.08.007

Vancouver

Chen S, Wang X, Xuan Q, Liu C, Su Y, Liu Z, et al. Concurrent loss of RB1 facilitates EGFR-TKI resistance in EGFR-mutant lung cancer by modulating histone crotonylation. Acta Pharmaceutica Sinica B. 2026;16(11):7307-7324. doi:10.1016/j.apsb.2026.08.007

BibTeX
@article{Chen2026,
  author = {Chen, Sihong and Wang, Xiaoyuan and Xuan, Qihao and Liu, Chang and Su, Youwei and Liu, Zongang and Jia, Lina and Ren, Yi and Cui, Wei and Fan, Xinyu and Wang, Lihui},
  title = {Concurrent loss of RB1 facilitates EGFR-TKI resistance in EGFR-mutant lung cancer by modulating histone crotonylation},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {7307--7324},
  doi = {10.1016/j.apsb.2026.08.007}
}
Kostenlos starten →